Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
The EU's Top Valsartan Lesson: Closely Examine Active Substance Manufacturing Processes
Jun 26 2020
•
By
Joanne S. Eglovitch
EU Lessons Learnt Report On Valsartan Crisis Focuses On Supply Chain • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance